A Transgenic Rat Model of Charcot-Marie-Tooth Disease

Sereda, Michael; Griffiths, Ian; Pühlhofer, Anja; Stewart, Helen; Rossner, Moritz J; Zimmermann, Frank; Magyar, Josef P; Schneider, Armin; Hund, Ernst; Meinck, Hans-Michael; Suter, Ueli; Nave, Klaus-Armin

doi:10.1016/S0896-6273(00)80128-2

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

A Transgenic Rat Model of Charcot-Marie-Tooth Disease

MPS-Authors

/persons/resource/persons182320

Nave, Klaus-Armin
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Sereda, M., Griffiths, I., Pühlhofer, A., Stewart, H., Rossner, M. J., Zimmermann, F., Magyar, J. P., Schneider, A., Hund, E., Meinck, H.-M., Suter, U., & Nave, K.-A. (1996). A Transgenic Rat Model of Charcot-Marie-Tooth Disease. Neuron, 16(5), 1049-1060. doi:10.1016/S0896-6273(00)80128-2.

引用: https://hdl.handle.net/21.11116/0000-000D-1F58-F

要旨

Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy in humans and has been associated with a partial duplication of chromosome 17 (CMT type 1A). We have generated a transgenic rat model of this disease and provide experimental evidence that CMT1A is caused by increased expression of the gene for peripheral myelin protein-22 (PMP22, gas-3). PMP22-transgenic rats develop gait abnormalities caused by a peripheral hypomyelination, Schwann cell hypertrophy (onion bulb formation), and muscle weakness. Reduced nerve conduction velocities closely resemble recordings in human patients with CMT1A. When bred to homozygosity, transgenic animals completely fail to elaborate myelin. We anticipate that the CMT rat model will facilitate the identification of a cellular disease mechanism and serve in the evaluation of potential treatment strategies.